Answers are grounded in this paper and cite their sources.
This study reports, for the first time, the design, synthesis, and characterization of thermoresponsive hybrid nanoparticles composed of silk fibroin (SF) and poly(N-vinylcaprolactam) (PNVCL) for controlled drug delivery. The system was produced using a grafting-from approach based on RAFT polymerization of N-vinylcaprolactam directly from the fibroin backbone. The resulting SF–PNVCL nanoparticles, with mean diameters below 200 nm, successfully integrate the biocompatibility of SF with the temperature-sensitive behavior of PNVCL. Hybrid formation and structural integrity were confirmed by FTIR, TGA, and PXRD analyses. Curcumin was used as a model hydrophobic agent and presented efficient encapsulation (EE ≈ 42%), exhibiting a temperature-triggered release profile, with markedly higher release at 40 °C compared to 25 °C. Cytotoxicity assays showed that curcumin-loaded hybrids were non-toxic to normal human fibroblasts (MRC-5), while promoting pronounced cytotoxicity in 4T1 breast cancer cells. Overall, these findings demonstrate that SF–PNVCL hybrid nanoparticles represent a promising new class of protein–polymer carriers capable of stimuli-responsive, controlled drug release, highlighting their potential for future biomedical applications.
No takes yet. Share an insight, caveat, or question.
Maia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: